Medical Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

Using proteomic mass spectrometry imaging to detect malignant melanoma: an interview with Stephen Turner

Today, using anatomic pathology, the differences in appearance of a normal or a malignant lesion can be difficult to tell when just using light microscopy.

2 Jun 2016

Portable breath sensor to detect lifestyle diseases? An interview with Osamu Tsuboi, Fujitsu Laboratories

Generally, it is thought that there is a connection between concentrations of ammonia and liver disease, such as fatty liver and cirrhosis, Helicobacter pylori (H. pylori) infection, and kidney failure.

31 May 2016

Overcoming barriers in autism research: an interview with Gahan Pandina

There are currently no medications which address the core symptoms of ASD, and a significant barrier to their development is that researchers have historically lacked effective methods for measuring clinical outcomes.

30 May 2016

Creating reference standards for cannabis testing: an interview with Adam Ross

The main applications for cannabis testing is to ensure that the product produced, whether the flower itself, tinctures, edibles, etc. contain acceptable levels of approved pesticide or other residues leftover from the growing or processing process.

25 May 2016

Tackling Zika: are insect repellents the answer? An interview with Bruno Jactel

The repellents that are used today are mostly based on what we call chemical pesticides. These products are used to repel mosquitoes as well as ticks. They are very broadly used, but there are different issues surrounding their use.

19 May 2016

Empowering mobile health: an interview with Dr Rich Khatib and Dan Vahdat

overview of Medopad and how you deliver patient information to mobile devices? Medopad is a mobile health technology company. We focus on developing software within the mobile health industry. Mobile health, from our perspective, is an industry that really was invented with the iPad.

18 May 2016

Simultaneous DNA, RNA and protein analysis to enhance cancer immunology studies: an interview with Dr Joseph Beechem

Cancer immunology is all about how your immune cells are going to fight and kill your tumor cells. If you look at the pure genetic code of a T-cell that's going to kill your tumor compared to the same cell that has been “put-to-sleep” (by the tumor), the pure genetic DNA content of those two cells are identical.

From NanoString Technologies 11 May 2016

Guide to advance directives: an interview with Dr Lisa Price

An advance directive is a very specific legal document that details the medical treatments you want, and, importantly, don’t want, if you’re unable to communicate with a physician. This may happen as a result of a critical illness that could make you confused or unable to speak.

6 May 2016

BioAFM Advancements

In this interview, News Medical talks to Dr. Thomas Mueller of Bruker Nano surface, about the advances in BioAFM.

From Bruker Nano Surfaces and Metrology 3 May 2016

Transforming MR images into body composition measurements: an interview with Olof Leinhard

Today's medical science utilizes relatively simple anthropometric measures that describe the body, such as body mass index (BMI) and waist circumference. All of these measures are approximations of the body with the intention to characterize what's inside reflecting underlying phenomena that underpin the risk for different diseases.

26 Apr 2016

Artificial intelligence in healthcare: an interview with Dr Ehud Reiter

Artificial Intelligence has made huge advances in recent years in many areas, including language processing, vision, and machine learning; we are also seeing the emergence of platforms that integrate different kinds of AI, such as IBM Watson (Arria is a Watson ecosystem partner).

20 Apr 2016

Reducing hair loss during chemotherapy: an interview with Richard Paxman

The basic principle of chemotherapy is to damage the mitotic and metabolic processes in the cancer cells. The chemotherapy doesn't just target the cancer cells, it also targets the healthy cells, specifically ones that are rapidly dividing - our hair follicles are also rapidly dividing. We see damage to those hair cells, which then causes the hair to fall out.

From Paxman 19 Apr 2016

How will IoT impact healthcare? An interview with David Doherty

IoT is a term being used to help communicate the complex transition that's happening as Mobile transforms the Internet into a network of devices. The idea of the internet being something we go to and use a mouse to navigate is dead as we now can talk to SIRI on our mobiles to immediately summon Uber cars and buy things from Amazon that will arrive in just a few hours. Welcome to a new world!

18 Apr 2016

Latest trends in robotic surgery: an interview with Dr. Patrick Ross, Chairman of Surgery for Main Line Health

When new technology becomes available, surgical or otherwise, there are those who adopt early, and those who hold on to previous familiar methods.

6 Apr 2016

Pioneering progress on ADPKD: an interview with Tess Harris

ADPKD is a chronic, progressive and inherited kidney disease characterized by fluid-filled cysts that develop in the kidneys and other organs. It is the most common inherited kidney disease, and affects millions worldwide.

10 Mar 2016

How can electronic ink help patients? An interview with Giovanni Mancini

Electronic ink is basically what the name says. It's made of ink, the same ink particles that you see on a printed paper that comes out of an inkjet printer. We use black and white pigments that we add certain properties to that allow us to move the pigments around.

2 Mar 2016

Increasing medication adherence: an interview with Dr Alejandro (Alex) Jaimes

Adherence applies to multiple levels of healthcare. Before a drug goes on the market it has to undergo testing in clinical trials: participants take the study drug and report how well the drug works, along with any side effects.

22 Feb 2016

Simulation training for prenatal and neonatal emergencies

It's difficult to practice skills on preterm babies who are in neonatal intensive care units (NICU). The complications associated with preterm babies can be varied and infrequent, making it hard for staff to develop their skills set.

From Laerdal 17 Feb 2016

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Nasogastric tubes are placed directly into the stomach in order to feed or medicate patients. If an NG tube accidentally goes into the lung instead, which can happen, it can cause serious harm to the patient, with food, liquid or medication potentially entering the lung.

15 Feb 2016

Simulated practice in healthcare: an interview with Andy Anderson

There's around 95 to 100 simulation centres across the NHS in secondary care. These centres are used for a whole variety of training, practicing of skills and recreating incidents so that staff can prevent them recurring.

10 Feb 2016